TrianglePUBLICATIONS · 15486072
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2005 Feb 1
- First author
- Faderl S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Faderl S
- type
- Author
- name
- Gandhi V
- type
- Author
- name
- O'Brien S
- type
- Author
- name
- Bonate P
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Estey E
- type
- Author
- name
- Beran M
- type
- Author
- name
- Wierda W
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Ferrajoli A
- type
- Author
- name
- Estrov Z
- type
- Author
- name
- Giles FJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Faderl S
- type
- Author
- name
- Gandhi V
- type
- Author
- name
- O'Brien S
- type
- Author
- name
- Bonate P
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Estey E
- type
- Author
- name
- Beran M
- type
- Author
- name
- Wierda W
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Ferrajoli A
- type
- Author
- name
- Estrov Z
- type
- Author
- name
- Giles FJ
- type
- Author
- bibliography ids
- nci-bib-18532b85fcde184b0c318db8
- book metadata
- content sha256
- a132bf8e59705921fc19281167a9ffd975bed7f10a084a2c6b8f742490a80319
- document type
- citation
- dois
- 10.1182/blood-2004-05-1933
- electronic publication date
- display
- 2004 Oct 14
- precision
- day
- year
- 2004
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15486072
- immutable id
- pubmed:15486072@a132bf8e59705921fc19281167a9ffd975bed7f10a084a2c6b8f742490a80319
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 3
- name
- Blood
- nlm unique id
- 7603509
- pages
- 940-7
- volume
- 105
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15486072
- provenance
- batch id
- 97b9e848a139d5f8d462
- provider
- NCBI PubMed ESummary
- record sha256
- 9335b5b3cea869905e946e52bb13fc1e2be20dec7769c414cf1b65f4780f8b98
- response sha256
- a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
- retrieved at
- 2026-09-09T23:45:57.930512+00:00
- publication date
- display
- 2005 Feb 1
- precision
- day
- year
- 2005
- publication types
- Clinical Trial
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.
Preserved source evidence · Not medical advice